{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:27:14Z","timestamp":1787027234163,"version":"build-2736575974"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>\n                    Prenatal exposure to valproic acid (VPA) is a risk factor for autism spectrum disorder (ASD) in humans and it induces autistic-like behaviors in rodents. Imbalances between GABAergic and glutamatergic neurotransmission and increased oxidative stress together with altered glutathione (GSH) metabolism have been hypothesized to play a role in both VPA-induced embriotoxicity and in human ASD. N-acetylcysteine (NAC) is an antioxidant precursor of glutathione and a modulator of glutamatergic neurotransmission that has been tested in ASD, although the clinical studies currently available provided controversial results. Here, we explored the effects of repeated NAC (150 mg\/kg) administration on core autistic-like features and altered brain GSH metabolism in the VPA (500 mg\/kg) rat model of ASD. Furthermore, we measured the mRNA expression of genes encoding for scaffolding and transcription regulation proteins, as well as the subunits of NMDA and AMPA receptors and metabotropic glutamate receptors mGLUR1 and mGLUR5 in brain areas that are relevant to ASD. NAC administration ameliorated the social deficit displayed by VPA-exposed rats in the three-chamber test, but not their stereotypic behavior in the hole board test. Furthermore, NAC normalized the altered GSH levels displayed by these animals in the hippocampus and nucleus accumbens, and it partially rescued the altered expression of post-synaptic terminal network genes found in VPA-exposed rats, such as\n                    <jats:italic>NR2a, MGLUR5, GLUR1<\/jats:italic>\n                    , and\n                    <jats:italic>GLUR2<\/jats:italic>\n                    in nucleus accumbens, and\n                    <jats:italic>CAMK2, NR1<\/jats:italic>\n                    , and\n                    <jats:italic>GLUR2<\/jats:italic>\n                    in cerebellum. These data indicate that NAC treatment selectively mitigates the social dysfunction displayed by VPA-exposed rats normalizing GSH imbalance and reestablishing the expression of genes related to synaptic function in a brain region-specific manner. Taken together, these data contribute to clarify the behavioral impact of NAC in ASD and the molecular mechanisms that underlie its effects.\n                  <\/jats:p>","DOI":"10.3389\/fpsyt.2022.851679","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:39:46Z","timestamp":1645749586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["N-Acetylcysteine Mitigates Social Dysfunction in a Rat Model of Autism Normalizing Glutathione Imbalance and the Altered Expression of Genes Related to Synaptic Function in Specific Brain Areas"],"prefix":"10.3389","volume":"13","author":[{"given":"Sara","family":"Schiavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Piemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41398-019-0608-1","article-title":"Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates","volume":"9","author":"Zhao","year":"2019","journal-title":"Transl Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"F90","DOI":"10.1136\/adc.2004.067421","article-title":"Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes","volume":"91","author":"Kini","year":"2006","journal-title":"Arch Dis Childh Fetal Neonatal Ed."},{"key":"B4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","article-title":"Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature","volume":"98","author":"Kozma","year":"2001","journal-title":"Am J Med Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"712758","DOI":"10.1155\/2013\/712758","article-title":"What we have learned about autism spectrum disorder from valproic acid","volume":"2013","author":"Chomiak","year":"2013","journal-title":"Patholog Res Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A. male with fetal valproate syndrome and autism","volume":"39","author":"Williams","year":"1997","journal-title":"Dev Med Child Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2013a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol Teratol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"107477","DOI":"10.1016\/j.neuropharm.2018.12.024","article-title":"Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder","volume":"159","author":"Tartaglione","year":"2019","journal-title":"Neuropharmacology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000509109","article-title":"A systematic review of the valproic-acid-induced rodent model of autism","volume":"42","author":"Chaliha","year":"2020","journal-title":"Dev Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ejn.13595","article-title":"Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation\/inhibition imbalance","volume":"47","author":"Bozzi","year":"2018","journal-title":"Eur J Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"B14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","article-title":"Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis","volume":"78","author":"Bateup","year":"2013","journal-title":"Neuron."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front Neural Circuits."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.19.001.2009","article-title":"Enhanced long-term microcircuit plasticity in the valproic Acid animal model of autism","volume":"1","author":"Silva","year":"2009","journal-title":"Front Synaptic Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cereb Cortex."},{"key":"B20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12035-014-8987-z","article-title":"MeCP2 modulates sex differences in the postsynaptic development of the valproate animal model of autism","volume":"53","author":"Kim","year":"2016","journal-title":"Mol Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","article-title":"Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring","volume":"49","author":"Kim","year":"2014","journal-title":"Mol Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science."},{"key":"B23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/10937400600882079","article-title":"Evidence of toxicity, oxidative stress, and neuronal insult in autism","volume":"9","author":"Kern","year":"2006","journal-title":"J Toxicol Environ Health B Crit Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cyto.2014.10.027","article-title":"Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model","volume":"71","author":"Hegazy","year":"2015","journal-title":"Cytokine."},{"key":"B25","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.neuropharm.2020.107975","article-title":"5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats","volume":"168","author":"Matsuo","year":"2020","journal-title":"Neuropharmacology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1196\/annals.1300.023","article-title":"N-acetyl cysteine-induced blockade of cocaine-induced reinstatement","volume":"1003","author":"Baker","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fnbeh.2014.00219","article-title":"Activation of mGluR2\/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism","volume":"8","author":"Chen","year":"2014","journal-title":"Front Behav Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.4088\/JCP.15r09984","article-title":"N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis","volume":"77","author":"Fernandes","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch Gen Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/cap.2019.0041","article-title":"N-Acetylcysteine for pediatric obsessive-compulsive disorder: a small pilot study","volume":"30","author":"Li","year":"2020","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2174\/1570159X19666201230144109","article-title":"The multifaceted therapeutic role of N-Acetylcysteine (NAC) in disorders characterized by oxidative stress","volume":"19","author":"Raghu","year":"2021","journal-title":"Curr Neuropharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s12035-014-8705-x","article-title":"The glutathione system: a new drug target in neuroimmune disorders","volume":"50","author":"Morris","year":"2014","journal-title":"Mol Neurobiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MCO.0000000000000134","article-title":"Glutathione redox imbalance in brain disorders","volume":"18","author":"Gu","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105437","DOI":"10.1016\/j.phrs.2021.105437","article-title":"The impact of glutathione metabolism in autism spectrum disorder","volume":"166","author":"Bjorklund","year":"2021","journal-title":"Pharmacol Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11064-012-0775-4","article-title":"Brain region-specific glutathione redox imbalance in autism","volume":"37","author":"Chauhan","year":"2012","journal-title":"Neurochem Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic Biol Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.12740\/PP\/89948","article-title":"Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle","volume":"53","author":"Waligora","year":"2019","journal-title":"Psychiatr Pol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2020.07.017","article-title":"The role of glutathione redox imbalance in autism spectrum disorder: a review","volume":"160","author":"Bjorklund","year":"2020","journal-title":"Free Radic Biol Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13229-016-0088-6","article-title":"A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder","volume":"7","author":"Wink","year":"2016","journal-title":"Mol Autism."},{"key":"B42","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/tp.2012.61","article-title":"Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain","volume":"2","author":"Rose","year":"2012","journal-title":"Transl Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br J Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3892\/mmr.2017.6787","article-title":"N-acetylcysteine ameliorates repetitive\/stereotypic behavior due to its antioxidant properties without activation of the canonical Wnt pathway in a valproic acid-induced rat model of autism","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol Med Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00213-012-2837-3","article-title":"N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking","volume":"225","author":"Ramirez-Nino","year":"2013","journal-title":"Psychopharmacology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.psyneuen.2010.03.005","article-title":"Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo","volume":"35","author":"Hill","year":"2010","journal-title":"Psychoneuroendocrinology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","article-title":"Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats","volume":"32","author":"Trezza","year":"2012","journal-title":"J Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e20750","DOI":"10.7554\/eLife.20750","article-title":"Sam68 promotes self-renewal and glycolytic metabolism in mouse neural progenitor cells by modulating Aldh1a3 pre-mRNA 3'-end processing","volume":"5","author":"La Rosa","year":"2016","journal-title":"eLife."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1038\/tp.2013.51","article-title":"Redox metabolism abnormalities in autistic children associated with mitochondrial disease","volume":"3","author":"Frye","year":"2013","journal-title":"Transl Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12640-012-9354-3","article-title":"Excitotoxicity in the pathogenesis of autism","volume":"23","author":"Essa","year":"2013","journal-title":"Neurotox Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/archdischild-2013-305636","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"99","author":"Smith","year":"2014","journal-title":"Arch Dis Childh Educ Pract Ed."},{"key":"B57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/7854_2015_404","article-title":"Perinatal influences of valproate on brain and behaviour: an animal model for autism","volume":"29","author":"Ranger","year":"2016","journal-title":"Curr Top Behav Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/0004867420952540","article-title":"Effectiveness of N-acetylcysteine in autism spectrum disorders: a meta-analysis of randomized controlled trials","volume":"55","author":"Lee","year":"2021","journal-title":"Aust N Z J Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-9-35","article-title":"The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis","volume":"9","author":"Main","year":"2012","journal-title":"Nutr Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1007\/s11356-019-07315-z","article-title":"Metal-dependent nano-catalysis in reduction of aromatic pollutants","volume":"27","author":"Emam","year":"2020","journal-title":"Environ Sci Pollut Res Int."},{"key":"B62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/B978-0-323-52733-0.00018-5","article-title":"Chapter 18 - toxicity of nanoparticles: etiology and mechanisms","volume-title":"Antimicrobial Nanoarchitectonics","author":"Crisponi","year":"2017"},{"key":"B63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.15252\/msb.20156487","article-title":"The gut microbiota modulates host amino acid and glutathione metabolism in mice","volume":"11","author":"Mardinoglu","year":"2015","journal-title":"Mol Syst Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/IJGM.S15618","article-title":"Role of glutathione in immunity and inflammation in the lung","volume":"4","author":"Ghezzi","year":"2011","journal-title":"Int J Gen Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00705812","article-title":"The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria)","volume":"52","author":"Skullerud","year":"1980","journal-title":"Acta Neuropathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed Pharmacother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/tid.12557","article-title":"Prevalence of polyoma BK virus infection among living-donor renal transplant recipients","volume":"18","author":"El Ansary","year":"2016","journal-title":"Transpl Infect Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0006-2952(00)00415-9","article-title":"Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and\/or lipopolysaccharide-induced activation","volume":"60","author":"McNaught","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.febslet.2004.10.074","article-title":"Glutamate-evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures","volume":"578","author":"Campisi","year":"2004","journal-title":"FEBS Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1254\/jphs.08R01CR","article-title":"Regulation of neuronal glutathione synthesis","volume":"108","author":"Aoyama","year":"2008","journal-title":"J Pharmacol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.pnpbp.2018.09.010","article-title":"The contribution of [1H] magnetic resonance spectroscopy to the study of excitation-inhibition in autism","volume":"89","author":"Ajram","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B72","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.neuroscience.2004.09.042","article-title":"Glutamate and GABA receptor signalling in the developing brain","volume":"130","author":"Lujan","year":"2005","journal-title":"Neuroscience."},{"key":"B73","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0269881118754680","article-title":"Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: therapeutic implications","volume":"32","author":"Olloquequi","year":"2018","journal-title":"J Psychopharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.biopsych.2011.07.035","article-title":"N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development","volume":"71","author":"das Neves Duarte","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fnbeh.2015.00343","article-title":"Targeting glia with N-acetylcysteine modulates brain glutamate and behaviors relevant to neurodevelopmental disorders in C57BL\/6J mice","volume":"9","author":"Durieux","year":"2015","journal-title":"Front Behav Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.biopsych.2011.10.024","article-title":"The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine","volume":"71","author":"Kupchik","year":"2012","journal-title":"Biol Psychiatry."},{"key":"B78","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fncel.2018.00470","article-title":"Synaptopathology involved in autism spectrum disorder","volume":"12","author":"Guang","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"a009886","DOI":"10.1101\/cshperspect.a009886","article-title":"Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities","volume":"4","author":"Zoghbi","year":"2012","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.pnpbp.2006.06.013","article-title":"Increased serum levels of glutamate in adult patients with autism","volume":"30","author":"Shinohe","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pnpbp.2012.01.017","article-title":"Valproic acid mediates the synaptic excitatory\/inhibitory balance through astrocytes\u2013a preliminary study","volume":"37","author":"Wang","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.851679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:39:51Z","timestamp":1645749591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.851679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":81,"alternative-id":["10.3389\/fpsyt.2022.851679"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.851679","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"851679"}}